A United Nations-backed organisation announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck’s Covid-19 pill to supply 105 developing countries.The Medicines Patent Pool said the deals would allow drug companies to make both the raw ingredients for molnupiravir and the finished product itself.Molnupiravir, developed by Merck and Ridgeback Therapeutics, has been reported to cut the hospitalisation rate in half among patients with…
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Covid-19 News Click Here